BioSpace.com
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel

Status: 301 Moved Permanently Location: http://www.marketwire.com/press-release/Peregrine-Pharmaceuticals-Announces-Results-From-Phase-II-Clinical-Trial-Bavituximab-NASDAQ-PPHM-1756257.htm